{
    "2019-07-29": [
        [
            {
                "time": "2018-01-02",
                "original_text": "US Indexes Close Mostly Lower on Monday",
                "features": {
                    "keywords": [
                        "Indexes",
                        "Close",
                        "Lower",
                        "Monday"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Dow Outperforms Ahead of Busy Week on Wall Street",
                "features": {
                    "keywords": [
                        "Dow",
                        "Outperforms",
                        "Busy Week",
                        "Wall Street"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "UPDATE 2-J&J says FTC probing efforts to protect arthritis drug Remicade",
                "features": {
                    "keywords": [
                        "J&J",
                        "FTC",
                        "probing",
                        "Remicade"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "J&J says FTC probing efforts to protect arthritis drug Remicade",
                "features": {
                    "keywords": [
                        "J&J",
                        "FTC",
                        "probing",
                        "Remicade"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "5 Top Stock Trades for Tuesday: SHOP, NFLX, JNJ",
                "features": {
                    "keywords": [
                        "Top Stock Trades",
                        "SHOP",
                        "NFLX",
                        "JNJ"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Dow Jones Edges Higher on Monday",
                "features": {
                    "keywords": [
                        "Dow Jones",
                        "Edges Higher",
                        "Monday"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Pfizer to Combine Off-Patent Drug Business With Mylan",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Combine",
                        "Off-Patent",
                        "Mylan"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "3 Healthcare Stocks With Rising Expectations",
                "features": {
                    "keywords": [
                        "Healthcare Stocks",
                        "Rising Expectations"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Why Johnson & Johnson Stock Isn’t a Buy… Yet",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Stock",
                        "Buy",
                        "Yet"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}